Generic Name: nintedanib

Pill with imprint Logo 150 is Brown, Capsule-shape and has been identified as Ofev 150 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.

Ofev is used in the treatment of Idiopathic Pulmonary Fibrosis; Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype; Systemic Sclerosis-Associated Interstitial Lung Disease and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Ofev 150 mg is not a controlled substance under the Controlled Substances Act (CSA).